AIM Rule 17 Schedule 2(g) Update

RNS Number : 5935G
Induction Healthcare Group PLC
30 March 2022
 

30 March 2022

 

Induction Healthcare Group PLC

("Induction", the "Company", or the "Group")

 

AIM Rule 17 Schedule 2(g) Update

 

Induction (AIM: INHC), a leading virtual care platform driving digital transformation of healthcare systems worldwide, announces the following information relating to directors' disclosure under Schedule Two, paragraph (g) of the AIM Rules for Companies:

 

Chris Spencer, non-executive Chairman, has been a director of a private company, Acea Health Limited, since 2 April 2018.  On 29 March 2022, Acea Health Limited entered into creditors voluntary liquidation.

 

 

ENQUIRIES

 

Induction

James Balmain, Chief Executive Officer

Guy Mitchell, Chief Financial Officer

Via Walbrook PR Ltd: induction@walbrookpr.com



Singer Capital Markets (Nominated Adviser and Broker)

+44 (0)20 7496 3000

Philip Davies / Kailey Aliyar




Walbrook PR Ltd 

induction@walbrookpr.com

Paul McManus / Stephanie Cuthbert

Mob: +44(0)7980 541 893 / +44 (0)7796 794 663

 

About Induction -   www.inductionhealthcare.com

Induction (AIM: INHC) Induction delivers a suite of software solutions through a single integrated platform that transforms care delivery. Our system-wide applications help healthcare providers and administrators to deliver care at any stage remotely as well as face-to-face - enabling a more flexible, efficient and positive experience for the communities they serve . Purpose built for integration with leading Electronic Medical Record (EMR) platforms, our products offer immediate stand-alone value that becomes even greater when integrated with pre-existing systems.

 

Used at scale by national and regional healthcare systems, as well non-health government services, our applications are relied upon by hundreds of thousands of clinicians and millions of patients across almost every hospital in the British Isles.  

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBKKBQCBKKCNN
UK 100